-CEO and directors buying in at 7.5 cents this Thursday
-6 million in cash and 4 million in rebates coming in (10 million in funding)
- drug developed and de risked over the past 4 years
- Target market 55 billion dollars
- Peers in same space 70-100 million market caps after pre clinical success
- 3 months away from first in human dose
- Backed by the Us defence department and de risked on current study from 2010
Worth the same as its finding funny. Keep dumping apparently there is no potential.
-CEO and directors buying in at 7.5 cents this Thursday -6...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 300 | 1 |
View Market Depth
| Last trade - 16.12pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.000 ( 2.82 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 6.9¢ | 6.9¢ | 15000 | ||
| Last updated 15.16pm 07/06/2024 ? | |||||
| NYR (ASX) Chart |
Day chart unavailable